Company Filing History:
2 out of 1,380 
2 out of 2 
1 out of 205 
Years Active: 2024-2025
Title: Olivier Bernus: Innovator in Cardiovascular Technology
Introduction
Olivier Bernus is a notable inventor based in Lacanau de Mios, France. He has made significant contributions to the field of cardiovascular technology, particularly in the diagnosis of arrhythmias. His innovative work has led to the development of a unique patent that enhances the understanding and treatment of heart conditions.
Latest Patents
Olivier Bernus holds a patent for "Electrode configurations for diagnosis of arrhythmias." This apparatus includes a shaft and an end effector at the distal end of the shaft. The end effector is designed to fit within an anatomical passageway of a subject's cardiovascular system. It features at least one electrode pair configured to contact cardiovascular tissue, allowing for the collection of electrocardiogram signals. Each electrode pair consists of first and second electrodes spaced apart along a longitudinal axis, with a gap area between them. The design ensures that the length of one electrode is equal to or greater than the gap length, and the ratio of the gap area to one electrode area is equal to or less than one.
Career Highlights
Throughout his career, Olivier Bernus has worked with prominent organizations in the medical field. He has been associated with Biosense Webster Ltd. in Israel and the Centre Hospitalier Universitaire (CHU) de Bordeaux. His work in these institutions has allowed him to apply his innovative ideas in practical settings, contributing to advancements in medical technology.
Collaborations
Olivier has collaborated with notable professionals in his field, including Shubhayu Basu and Meir Bar-Tal. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Olivier Bernus is a distinguished inventor whose contributions to cardiovascular technology have the potential to improve diagnostic methods for arrhythmias. His innovative patent reflects his commitment to advancing medical science and enhancing patient care.